More subtly, transgenic mice that have been engineered to overexpress miR-17∼92 by 2-fold in lymphocytes develop lymphoproliferative disease and autoimmunity and die prematurely, phenotypes that were shown to be partially a consequence of the translational repression of PTEN and Bim [30]. The gene discussed is BCL2L11; the disease is Autoimmunity.